Methods for treating gastroesophageal reflux disease
US6147093A · kind A · utility
6Cited by
5References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 1998 |
| Grant date | Nov 14, 2000 |
| Priority date | — |
| Expiry date | Jul 28, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods utilizing the optically pure (+) isomer of norcisapride are disclosed. This compound has surprisingly been found to be a potent drug for the treatment of disorders caused by gastrointestinal motility dysfunction. Finally, the (+) isomer of norcisapride also avoids certain adverse side effects and certain adverse drug interactions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.